Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in SEER — Seer, Inc.

CIK 886982 NEW YORK, NY
Back to SEER Full portfolio

Position in SEER

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$409,418
+$83,208 QoQ
Shares Held
246,638
+27.0% QoQ
Ownership
0.445%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 59 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SEER Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. SEER ranks #295 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in SEER

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $409,418 246,638
2026-03-31 $326,210 194,173
2025-12-31 $386,226 211,053
2025-09-30 $405,383 186,813
2025-06-30 $343,387 160,462
2025-03-31 $288,815 170,897
2024-12-31 $260,392 112,724
2024-09-30 $281,630 142,960
2024-06-30 $748,751 445,686
2024-03-31 $263,527 138,699
2023-12-31 $326,997 168,556
2023-09-30 $337,497 152,714
2023-06-30 $488,047 114,297
2023-03-31 $408,252 105,765
2022-12-31 $673,640 116,145
2022-09-30 $2,193,492 283,397
2022-06-30 $2,438,068 272,410
2022-03-31 $901,019 59,122
2021-12-31 $1,485,934 65,144
2021-09-30 $771,262 22,336
2021-06-30 $876,799 26,748
2021-03-31 $1,472,488 29,438
2020-12-31 $8,698,050 154,935